Orion Health Awarded Defense Healthcare Management System Modernization Program Subcontract

Boston, MA, October 5, 2015—As a team member for the Leidos Partnership for Defense Health, Orion Health™ is pleased to be part of the team that has been awarded a contract by the Department of Defense (DoD) to provide an electronic health record (EHR) off-the-shelf solution, integration activities and deployment across the Military Health System. The contract, known as the Defense Healthcare Management System Modernization (DHMSM), is an initiative designed to modernize the military’s healthcare system in a meaningful way, enabling patients and clinicians to capture and share health data that can improve the continuity and quality of care for those who serve and have served our country and their families.

Modernizing the medical records of the millions of service members and their families is vitally important to DoD and our nation. DHMSM will continue the DoD’s leadership in utilizing the best healthcare technology, and can help improve medical outcomes and support the medical readiness of the U.S. military.

“Orion Health is proud to be part of the Leidos Partnership for Defense Health, the team that has been selected as the best value solution for the DHMSM contract,” said Paul Viskovich, President, Orion Health. “Together, our qualified and experienced team is working with the Department of Defense to deliver a world class interoperable electronic health records solution for our nation’s armed forces, their families and beneficiaries. We look forward to the work ahead and are committed to improving access to comprehensive healthcare data in order to facilitate improved clinical outcomes for our deserving men and women in uniform.”

The DoD has selected Orion Health’s Rhapsody Integration Engine®, which is designed for rapid interoperability between healthcare IT systems, regardless of technology or standards. Rhapsody will provide the required link between the DoD’s Cerner EHR system and the civilian facilities that provide care to over 50 percent of military personnel. Through continuous innovation, Rhapsody provides a comprehensive set of tools to simplify complex healthcare interoperability, and is the first integration engine to implement the new HL7® FHIR® standard.

Rhapsody is used by thousands of organizations in the United States and around the world, including hospitals, IDNs, software companies, public health agencies, health information exchanges (HIE), health plans and financial clearinghouses. The integration engine provides comprehensive support for an extensive range of communication protocols and message formats, and helps interface analysts and hospital IT administrators reduce their workload while meeting the complex technical challenges associated with making healthcare data accessible to all stakeholders.

About Orion Health, Inc.
Orion Health, a global leader in population health management, makes healthcare information available anywhere by providing healthcare IT connectivity in every U.S. state and in over 30 countries worldwide—facilitating care for tens of millions of patients every day. With an inherent ability to interconnect a wide variety of healthcare information systems, Orion Health’s Open Platform, with Rhapsody Integration Engine, facilitates data acquisition and aggregation within and among payer and provider organizations, accountable care organizations, governments and health information exchanges.  Open Platform stands alone as the foundation for population health management initiatives or can be combined with Orion Health’s own seamlessly integrated applications for analytics, care coordination, and patient engagement to enable end to end population health management, improve care coordination, enhance quality of care and help reduce costs. For more information, visit www.orionhealth.com.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.